Description

Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone (GHRH), engineered to stimulate pituitary receptor activity in research models. It has been widely studied in both preclinical and clinical settings for its role in endocrine signaling and metabolic pathway regulation.

In experimental environments, Tesamorelin has been investigated for its interaction with growth hormone pathways, receptor activation, and downstream signaling cascades, making it a valuable compound for studying hormonal regulation and peptide-mediated endocrine processes.

Its structural modifications enhance stability compared to native GHRH, allowing for more consistent activity in controlled laboratory and experimental models.

Key Features:

Chemical Name: Tesamorelin
Molecular Formula: C₂₂₁H₃₆₆N₇₂O₆₇S
CAS Number: 218949-48-5
Amino Acid Sequence:
Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg (modified GHRH analog)

Physical Form: Lyophilized powder
Compound Class: Synthetic peptide / GHRH analog
Purity: ≥98% (HPLC)
Storage Conditions: Store at 36–46°F (2–8°C) in a dry, light-protected environment.

Common Research Pairings:

Tesamorelin is sometimes studied alongside other compounds in endocrine and metabolic research, including:

• Ipamorelin – investigated in growth hormone secretagogue pathway studies
• CJC-1295 (no DAC) – studied in comparative GHRH analog research
• IGF-1 LR3 – explored in downstream growth factor signaling models
• AOD-9604 – examined in metabolic pathway research

These combinations are referenced strictly within controlled research environments to evaluate complementary biochemical mechanisms.

Research References:

• Falutz, J. et al. (2010). Tesamorelin and its role in growth hormone pathway research. New England Journal of Medicine.
• Stanley, T. L. et al. (2014). Effects of GHRH analogs on endocrine signaling pathways. Journal of Clinical Endocrinology & Metabolism.
• Biller, B. M. K. et al. (2011). Pharmacological properties of Tesamorelin in clinical research. Endocrine Practice.

(References provided for informational and research context only.)

Important Notice:

This product is intended for research use only. It is not for human or veterinary use. It is not intended to diagnose, treat, cure, or prevent any disease. Use is restricted to qualified professionals in controlled laboratory environments.